Publications: View by Years
Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study.. Public health genomics. 18(2), 78-86.(2015).
Associations between self-referral and health behavior responses to genetic risk information.. Genome medicine. 7(1), 10.(2015).
How can psychological science inform research about genetic counseling for clinical genomic sequencing?. Journal of genetic counseling. 24(2), 193-204.(2015).
Distinct communication patterns during genetic counseling for late-onset Alzheimer's risk assessment. Patient education and counseling. 94(2), 170-9.(2014).
Emerging issues in public health genomics. Annual review of genomics and human genetics. 15, 461-80.(2014).
Public beliefs and knowledge about risk and protective factors for Alzheimer's disease. Alzheimer's & Dementia : the journal of the Alzheimer's Association.(2014).
Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues. Progress in neurobiology. 110, 89-101.(2013).
Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination. Psychology & Health. 28(4), 434-49.(2013).
Tactical, strategic, and life-goal self-regulation of driving by older adults: development and testing of a questionnaire. Journal of safety research. 46, 107-17.(2013).
On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?. Medical decision making. 33(1), 71-7.(2013).
Amyloid imaging, risk disclosure and Alzheimer’s disease: ethical and practical issues. Neurodegenerative disease management. 3(3), 219 - 229.(2013).
Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies. Current genetic medicine reports. 1(3), 182-200.(2013).
Preferences among diseases on a genetic susceptibility test for common health conditions: an ancillary study of the multiplex initiative. Public health genomics. 15(6), 322-6.(2012).
Genetic testing for risk of Alzheimer’s disease: benefit or burden?. Neurodegenerative disease management. 2(2), 141-44.(2012).
Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. Journal of genetic counseling. 21(3), 440-7.(2012).
Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing. Genetics in medicine : official journal of the American College of Medical Genetics. 14(2), 268-73.(2012).